tiprankstipranks
Advaxis Clarifies CMO Bonus Terms Amid Asset Sale
PremiumCompany AnnouncementsAdvaxis Clarifies CMO Bonus Terms Amid Asset Sale
2M ago
Advaxis Asset Sale Approved by Majority Shareholder Vote
PremiumCompany Announcements
Advaxis Asset Sale Approved by Majority Shareholder Vote
3M ago
Advaxis Executes Strategic Unregistered Equity Sales
PremiumCompany Announcements
Advaxis Executes Strategic Unregistered Equity Sales
3M ago
Advaxis Announces Definitive Agreement with Ayala Pharmaceuticals
PremiumCompany AnnouncementsAdvaxis Announces Definitive Agreement with Ayala Pharmaceuticals
3M ago
Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock
PremiumThe Fly
Immunome to acquire AL102 from Ayala for $20M in cash, $30M in stock
3M ago
Ayala Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
PremiumThe Fly
Ayala Pharmaceuticals downgraded to Neutral from Buy at Ladenburg
5M ago
Ayala Pharmaceuticals closes merger with Biosight
PremiumThe FlyAyala Pharmaceuticals closes merger with Biosight
6M ago
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
PremiumPress Releases
Ayala Pharmaceuticals Announces Closing of Merger with Biosight
6M ago
Ayala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Ayala Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Corporate Update
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100